Home
About
FAQ
History (35)
Coated Materials, Biocompatible
Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.
Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering.
Coal Tar
Should patients stop their biologic treatment during the COVID-19 pandemic.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Should patients stop their biologic treatment during the COVID-19 pandemic.
Bashyam AM, Feldman SR. Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020 06; 31(4):317-318.
View in:
PubMed
subject areas
Biological Products
Coronavirus Infections
Humans
Pneumonia, Viral
Psoriasis
authors with profiles
Steven R. Feldman MD, PhD